domly selected. Clinical examination and laboratory investigations were done for all patients. Results were subjected to the international Sokal scoring system and compared with other studies.
Findings: The mean age of the study group was 42.8 ± 13.23 years (range 15-87). The male-to-female ratio was 1:1.08. The most common symptoms at onset were fatigue, weight loss, and abdominal fullness. At presentation, the mean white-cell count was 164,000/lL, and the mean percentage of blast cells was 3% in peripheral blood and 4% in marrow. Presence of the Philadelphia chromosome and BCR/ABL gene was available for 18 cases and was positive for all. According to the International Sokal Scoring System, patients were divided into three groups: group A patients with good prognosis (91%), group B with moderate prognosis (7%), and group C with poor prognosis (2%).
Interpretation: The mean age at presentation for CML in this study was lower than in developed countries. Significant prognostic indicators were platelet count, and peripheral and marrow blast-cell percentage; a high count and high percentages were associated with poor prognosis. Findings: Nine patientsÕ medical records were reviewed; six (66.7%) of the patients were male. Median age was 53 years (range 30-68) with peak incidence of olfactory neuroblastoma in the sixth decade. The mean duration of symptoms prior to diagnosis was 6.8 months (2-24). The most common presenting symptoms were nasal obstruction (55%) and orbital symptoms (44%). 66% of patients had Kadish stage C disease and the rest had stage B. Onethird of patients had nodal metastases initially, and all had locally 
